Cite
MLA Citation
Kei Sakamoto et al.. “A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men.” Clinical pharmacology in drug development, vol. 9, no. 7, 2020, pp. 833–840. http://access.bl.uk/ark:/81055/vdc_100112024345.0x00000d